Predictors of clinical response in patients with high risk acute myeloid leukemia receiving treatment with the histone deacetylase inhibitor sodium valproate.

C Craddock, C Bradbury, S Narayanan, A Rye, S Basu, A MacWhannell, A Sawers, M Cook, M Griffiths, D Grimwade, C Bunce, B Turner

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Article number2791
Pages (from-to)782a - 782a
Issue number11
Publication statusPublished - 2005
Event47th Meeting and Exposition of the American Society of Hematology - Atlanta, GA, United States
Duration: 10 Dec 200513 Dec 2005

Cite this